Perioperative Analgesia Using Ultrasound (US) Guided Transversus Abdominis Plane (TAP) Block

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2014 by King Saud University
Sponsor:
Information provided by (Responsible Party):
A.Eldawlatly, King Saud University
ClinicalTrials.gov Identifier:
NCT00819962
First received: January 6, 2009
Last updated: July 19, 2014
Last verified: July 2014
  Purpose

Perioperative analgesia using US guided TAP block


Condition Intervention Phase
Postoperative Pain
Drug: Bupivacaine
Other: TAP
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by King Saud University:

Primary Outcome Measures:
  • Pain relief [ Time Frame: after US TAP block ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 42
Study Start Date: September 2014
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
TAP
ksu
Drug: Bupivacaine
Local anesthetic
Other: TAP

Detailed Description:

Perioperative analgesia using US guided TAP block

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adult undergoing laparoscopic cholecystectomy

Exclusion Criteria:

  • history of cardiorespiratory disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00819962

Contacts
Contact: abdelazeem a dawlat, md 4692007 dawlatly@ksu.edu.sa

Locations
Saudi Arabia
A Dawlatly
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Saud University
  More Information

No publications provided

Responsible Party: A.Eldawlatly, Professor of Anesthesia, King Saud University
ClinicalTrials.gov Identifier: NCT00819962     History of Changes
Other Study ID Numbers: 08-652
Study First Received: January 6, 2009
Last Updated: July 19, 2014
Health Authority: Saudi Arabia: Ethics Committee

Additional relevant MeSH terms:
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Signs and Symptoms
Bupivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on July 29, 2014